BUZZ-US-listed shares of Zai Lab slide after commencing $200 mln stock offering** U.S.-listed shares of China-based drug developer Zai Lab ZLAB.O fall 6% to $28.11 after the bell
** ZLAB commences public offering of $200 mln of American depositary shares
** Company plans to use the proceeds for general corporate purposes
** ZLAB has 98 mln outstanding shares, with a capitalization of $3 bln market, according to data compiled by LSEG
** Goldman Sachs, Jefferies and Leerink Partners are the joint book-running managers for the offering
** As of last close, ZLAB shares up 9.6% YTD
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments